lymphoma
Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing
The companies have launched an initiative to improve patient access to EZH2Â mutation testing for patients with relapsed or refractory follicular lymphoma.
Barbara Ann Karmanos Cancer Institute Receives $325K Lymphoma Research Grant
The grant will fund a pilot study measuring circulating tumor DNA to help identify patients likely to relapse after autologous stem cell transplantation.
NCI researchers performed a multi-platform study to elucidate the factors that can contribute to a patient's better-than-expected response to a drug.
The Swiss-American bioinformatics company touts its networks of multimodal data and numerous partnerships as it looks to support "data-driven medicine."
T Cell Receptor Repertoire Linked to Anti-PD-1 Therapy Response in Hodgkin Lymphoma
Therapy was most effective in patients with a diverse baseline repertoire of T cell receptors and an associated expansion of singleton clones during treatment.